Eisai, Eurofarma to Develop Anticancer Agent in Latin America
By
Eisai’s research subsidiary, Morphotek, a biotechnology company headquartered in Exton, Pennsylvania, has signed an exclusive licensing agreement with Eurofarma Laboratórios, a São Paulo, Brazil-based pharmaceutical company, to develop and commercialize…
Sarepta, Summit Partner in Muscular Dystrophy Drug Pipeline
By
Sarepta Therapeutics, a Cambridge, Massachusetts-based biopharmaceutical company focused on RNA-targeted therapeutics, has formed a collaboration with Summit Therapeutics, an Oxfordshire, UK-based biopharmaceutical company, which grants Sarepta rights in Europe, Turkey, and…
Amgen, Nuevolution in Oncology and Neuroscience Pact
By
Amgen has formed a multiple-target research collaboration with Nuevolution, a Copenhagen, Denmark -based biotechnology company focused on small-molecule drug discovery, to develop and commercialize therapeutics in oncology and neuroscience. Nuevolution…